Persistence on HIV preexposure prophylaxis medication over a 2‐year period among a national sample of 7148 PrEP users, United States, 2015 to 2017

INTRODUCTION: Persistence on preexposure prophylaxis for HIV prevention (PrEP) medication has rarely been reported for periods greater than one year, or in real‐world settings. This study used pharmacy fill records for PrEP users from a national chain pharmacy to describe persistence on PrEP medicat...

Descripción completa

Detalles Bibliográficos
Autores principales: Coy, Kelsey C, Hazen, Ronald J, Kirkham, Heather S, Delpino, Ambrose, Siegler, Aaron J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378757/
https://www.ncbi.nlm.nih.gov/pubmed/30775846
http://dx.doi.org/10.1002/jia2.25252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378757/
https://www.ncbi.nlm.nih.gov/pubmed/30775846
http://dx.doi.org/10.1002/jia2.25252

Ejemplares similares